These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3460 related articles for article (PubMed ID: 19688670)

  • 1. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
    Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
    Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.
    Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A
    Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
    Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session].
    Heilmaier C; Sutter R; Lutz AM; Seifert B; Willmann JK
    Rofo; 2008 May; 180(5):440-8. PubMed ID: 18438745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.
    Bernatik T; Seitz K; Blank W; Schuler A; Dietrich CF; Strobel D
    Ultraschall Med; 2010 Dec; 31(6):577-81. PubMed ID: 20740399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20  mm) and subcentimetric (≤ 10  mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial.
    Strobel D; Bernatik T; Blank W; Schuler A; Greis C; Dietrich CF; Seitz K
    Ultraschall Med; 2011 Dec; 32(6):593-7. PubMed ID: 22161556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Benign hepatic tumors: MRI features before and after administration of superparamagnetic contrast media].
    Bartolotta TV; Midiri M; Galia M; Carcione A; De Maria M; Lagalla R
    Radiol Med; 2001 Apr; 101(4):219-29. PubMed ID: 11398050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localisation of focal liver lesions to specific hepatic segments--comparison of multiphase spiral CT and MR imaging.
    Bobek-Billewicz B; Szurowska E; Zapaśnik A; Izycka-Swieszewska E; Gorycki T; Nowakowski M
    Folia Morphol (Warsz); 2002; 61(4):291-7. PubMed ID: 12725499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Focal liver lesion, incidental finding].
    Dietrich CF; Jenssen C
    Dtsch Med Wochenschr; 2012 Oct; 137(41):2099-116. PubMed ID: 23033169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parametric imaging with contrast-enhanced ultrasound: usefulness for characterization of dynamic effects of microvascularization for hepatocellular carcinoma and focal nodular hyperplasia.
    Zheng SG; Xu HX; Liu LN; Wang Y; Zhang YF; Guo LH; Liu C; Xu JM; Sun LP; Wu J
    Clin Hemorheol Microcirc; 2013; 55(3):375-89. PubMed ID: 23271200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of biphasic spiral CT, conventional and iron oxide enhanced MRI on therapy and therapy costs in patients with focal liver lesions].
    Helmberger T; Gregor M; Holzknecht N; Rau H; Scheidler J; Reiser M
    Rofo; 2000 Mar; 172(3):251-9. PubMed ID: 10778456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Integrated diagnosis of liver angioma: comparison of Doppler color ultrasonography, computerized tomography, and magnetic resonance].
    De Franco A; Monteforte MG; Maresca G; De Gaetano AM; Manfredi R; Marano P
    Radiol Med; 1997; 93(1-2):87-94. PubMed ID: 9380876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal liver lesions in cirrhosis: value of contrast-enhanced ultrasonography compared with Doppler ultrasound and alpha-fetoprotein levels.
    D'Onofrio M; Faccioli N; Zamboni G; Malagò R; Caffarri S; Fattovich G; Mucelli RP
    Radiol Med; 2008 Oct; 113(7):978-91. PubMed ID: 18779929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium.
    Bieze M; van den Esschert JW; Nio CY; Verheij J; Reitsma JB; Terpstra V; van Gulik TM; Phoa SS
    AJR Am J Roentgenol; 2012 Jul; 199(1):26-34. PubMed ID: 22733890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions.
    Miller FH; Hammond N; Siddiqi AJ; Shroff S; Khatri G; Wang Y; Merrick LB; Nikolaidis P
    J Magn Reson Imaging; 2010 Jul; 32(1):138-47. PubMed ID: 20578020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
    Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
    Karabacakoğlu A; Adigüzel Y; Karaköse S; Kayaçetin E; Haykir R
    Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis.
    Hussain SM; Terkivatan T; Zondervan PE; Lanjouw E; de Rave S; Ijzermans JN; de Man RA
    Radiographics; 2004; 24(1):3-17; discussion 18-9. PubMed ID: 14730031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal nodular hyperplasia in children following treatment of hemato-oncologic diseases.
    Freidl T; Lackner H; Huber J; Sovinz P; Moser A; Schroettner B; Schwinger W; Urban C
    Klin Padiatr; 2008; 220(6):384-7. PubMed ID: 18949676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 173.